Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer
ICON7 investigators
Research output: Contribution to journal › Article › peer-review
50Scopus
citations
Fingerprint
Dive into the research topics of 'Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer'. Together they form a unique fingerprint.